Whether youre dealing with old injuries or simply the wear and tear that comes with an active lifestyle, IGF-1 LR3 helps to maintain joint flexibility and may aid in reducing discomfort
Higher dose range: 300 to 500 mcg Some researchers push into higher dose ranges, often 300 to 500 mcg or occasionally higher

Ipamorelin (INN) (developmental code name NNC 26-0161) is a peptide selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS) and a growth hormone secretagogue.[2][3] It is a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 that was derived from GHRP-1.[4] Ipamorelin significantly increases plasma growth hormone (GH).[1][3][5] In addition, ipamorelin stimulates body weight gain in animals.[5] Like pralmorelin and GHRP-6, ipamorelin does not affect prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), or thyroid-stimulating hormone (TSH) levels.[3] However, unlike pralmorelin (GHRP-2) and GHRP-6, but similarly to growth hormone-releasing hormone (GHRH), ipamorelin does not stimulate the secretion of adrenocorticotropic hormone (ACTH) or cortisol, and is highly selective for inducing the secretion only of GH.[3] Ipamorelin Peptide is under active investigation in a number of cell culture and animal models

IGF-1 LR3 can activate satellite cells, the muscle stem cells responsible for creating entirely new muscle fibers
Prader-Willi Syndrome Treatment Prader-Willi syndrome is a genetic disorder that causes poor muscle tone and consistent feelings of hunger
Key Areas of Investigation: Dual-Pathway Receptor Synergism : Evaluating GHRHR and GHSR binding dynamics in vitro